Pharma D&S

IFLScience | January 20, 2017

There is a governmental website where you’re free to search how much money pharmaceutical companies are giving to doctors in the US. Simply by searching a practitioner's name, it will break down which companies have paid them and the nature of the payments, such as whether it was a consulting fee, research fee, travel and lodging expenses, grants, food and beverage, etc....

Telegraph Media Group | January 26, 2017

Johnson & Johnson is buying blood pressure specialist Actelion in an all-cash deal that values the company at $30bn (£23.8bn), following months of complex negotiation and marking the first big pharmaceuticals transaction of the year....

PharmiWeb Solutions | February 10, 2017

Research and Markets has announced the addition of the "Innovative Trends in eHealth for Pharma Development in Europe - Drug Discovery TOE" report to their offering. This edition of the Drug Discovery TOE depicts developments associated with innovations in eHealth for pharmaceutical development in Europe. The corresponding patent scenario and industry interactions are depicted, illustrating the advent of eHealth platforms in pharmaceutical development, with a special focus on European countries....

BioPharma Dive: Biotech and Pharma news | April 21, 2017

Valeant set the price for its recently approved psoriasis drug to $3,500 per month, or $42,000 a year, the company announced Friday....